Skip to main content

Table 3 Characteristics of patients aged 75 and over who were administered at least two psychotropic drugs and one long-half-life benzodiazepine (cases, N = 349) compared to four control groups of patients aged 75 and over who were not administered such a prescription during their hospital stay; Bordeaux, from July 2014 to July 2015

From: Appropriateness of psychotropic drug prescriptions in the elderly: structuring tools based on data extracted from the hospital information system to understand physician practices

Characteristics Cases (N=349) Control group 1a (N=573) Control group 2 b (N=5838) Control group 3 c (N=1601) Control group 4d (N=8282)
N % N % N % N % N %
Gender
 Male 139 40.0 193 33.7 2514 43.1 763 47.7 3980 48.1
 Female 210 60.0 380 66.3 3324 56.9 838 52.3 4302 51.9
Stay with high level of severity
 Yes 245 70.2 383 66.8 2794 47.9 751 46.9 1770 21.4
 No 104 29.8 190 33.2 3044 52.1 850 53.1 6512 78.6
Primary diagnosis during staye
 Cognitive symptoms 42 12.0 41 7.2 131 2.2 40 2.5 104 1.3
 Vascular dementia 20 5.7 10 1.7 20 0.3 6 0.4 17 0.2
 Mood symptoms 18 5.2 4 0.7 14 0.2 8 0.5 5 0.1
Psychiatric disorderse
 Dementia 127 36.4 167 29.1 795 13.6 193 12.1 595 7.2
 Mood disorders 93 26.6 179 31.2 627 10.7 132 8.2 217 2.6
 Anxiety disorders 94 26.9 168 29.3 569 9.7 197 12.3 243 2.9
 Alcohol addiction 26 7.4 21 3.7 145 2.5 43 2.7 131 1.6
Dependence 137 39.3 213 37.2 1153 19.7 370 23.1 844 10.2
Social status
 Living alone at home 21 6.0 32 5.6 241 4.1 46 2.9 173 2.1
 Requiring nursing home entry 18 5.2 27 4.7 161 2.8 43 2.7 64 0.8
  1. aControl group 1: patients who were administered two psychotropic drugs without any long half-life benzodiazepine
  2. bControl group 2: patients who were administered one psychotropic drug without any long half-life benzodiazepine
  3. c Control group 3: patients who were administered at least one long half-life benzodiazepine without any psychotropic drugs
  4. d Control group 4: patients who were not administered any psychotropic drugs nor any long half-life benzodiazepine
  5. eCodes of the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10): Cognitive symptoms (R41); Vascular Dementia (F01); Mood symptoms (R45); Dementia (F00, F01, F02, F03); Mood disorders (F32, F33, F38, F39); Anxiety disorders (F40, F41, F42, F43); Alcohol addiction (F10)